Parkinson’s disease drug ropinirole safely slowed the progression of ALS for over 6 months in a clinical trial (IMAGE)

Cell Press

Parkinson’s disease drug ropinirole safely slowed the progression of ALS for over 6 months in a clinical trial

Caption

Researchers tested the safety and efficacy of ropinirole in ALS patients in an early-phase clinical trial paired with stem cell research to explore ropinirole's mechanism of action.

Credit

Morimoto et al/Cell Stem Cell

Usage Restrictions

Credit must be given to the creator. Adaptations must be shared under the same terms.

License

CC BY-SA

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.